Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us ![]()
About
Global ChemShowGlobal ChemShow
Not Confirmed
Not Confirmed
19-20 December, 2025
BIO Partnering at JPMBIO Partnering at JPM
Not Confirmed
Not Confirmed
12-15 January, 2026
Biotech ShowcaseBiotech Showcase
Not Confirmed
Not Confirmed
12-14 January, 2026
List your booth number for exhibitions, ask us
CONTACT DETAILS




Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
Global ChemShowGlobal ChemShow
Industry Trade Show
Not Confirmed
19-20 December, 2025
BIO Partnering at JPMBIO Partnering at JPM
Industry Trade Show
Not Confirmed
12-15 January, 2026
Biotech ShowcaseBiotech Showcase
Industry Trade Show
Not Confirmed
12-14 January, 2026
Digital content

06 Dec 2025
// PHARMIWEB
https://www.pharmiweb.com/press-release/2025-12-06/ayrmid-reports-promising-new-real-world-data-on-motixafortide-for-stem-cell-mobilization-in-sickle-c

05 Dec 2025
// PHARMIWEB
https://www.pharmiweb.com/press-release/2025-12-05/fda-approves-omisirge-r-as-first-approved-cell-therapy-to-treat-severe-aplastic-anemia

28 Oct 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20251027168884/en/Gamida-Cell-Presents-Positive-Initial-Results-on-Treating-Severe-Aplastic-Anemia-SAA-with-Omidubicel

21 Nov 2024
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/biolinerx-and-ayrmid-ltd-enter-into-exclusive-license-agreement-to-commercialize-aphexda-motixafortide-through-gamida-cell-ltd-302312746.html

27 Mar 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2024/03/27/2853012/0/en/Gamida-Cell-Announces-Commencement-of-Restructuring-Process-Supported-by-Highbridge-Capital-Management.html

27 Mar 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2024/03/27/2853017/0/en/Gamida-Cell-Reports-Fourth-Quarter-and-Full-Year-2023-Financial-Results-and-Provides-Company-Update.html
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE